EMEA-002054-PIP01-16-M01

Key facts

Active substance
Odevixibat
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0316/2019
PIP number
EMEA-002054-PIP01-16-M01
Pharmaceutical form(s)
  • Capsule, hard
  • Age-appropriate oral liquid dosage form
Condition(s) / indication(s)
Treatment of Progressive Familial Intrahepatic Cholestasis
Route(s) of administration
Oral use
Contact for public enquiries
Albireo AB

Tel. +46 31741 14 80
E-mail: info@albireopharma.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating